Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now OTC Markets OTCPK - Delayed Quote • USD Protect Pharmaceutical Corporation (PRTT) Follow Compare 1.0300 -0.0700 (-6.36%) At close: February 21 at 3:00:00 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Protect Pharmaceutical Corp. Announces that KARINCA Logistics Merger Will Not Proceed ANKARA, Turkey, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. (OTC: PRTT) (“Company”) and Atlantic Logistics announce there will be no merger with KARINCA Logistics. The previous announcement on August 28, 2024, on the merger between KARINCA Logistics and PRTT should not be relied upon. During final due diligence at closing, an unforeseeable business issue arose, and Management did not issue shares or any other form of monetary exchange. Management will continue to update share Protect Pharmaceutical Corp. (PRTT) Finalizes the Merger with KARINCA Logistics ANKARA, Turkey, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. (OTC: PRTT) ($PRTT) (“Company”) announces it completed the necessary documentation to finalize the merger with KARINCA Logistics - www.karincalogistics.com. PRTT’s Management believes that the KARINCA Logistics merger should add substantial value to the Company’s overall operations, and it brings a talent pool of professionals, dedicated to the successful integration of the combined business operations. KARINCA Logist Protect Pharmaceutical Corp. (PRTT) Announces New CEO and New Director; Moves to Finalize the Karinca Logistics Merger ANKARA, Turkey, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. (OTC: PRTT) ("Company") announces the appointment of a new CEO, restructuring of the Board of Directors, and looks to finalize the merger agreement with Karinca Logistics - www.karincalogistics.com. The Company appointed Ozgur Ozcan as CEO and Director and George Athanasiadis as Director. Further, the Company accepted the resignations of Ali Yildiz as CEO and Tatiana Aleinikov as VP of Operations. The Board restructur Protect Pharmaceutical Corp. Issues Corporate Update ANKARA, Turkey, July 01, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp.'s (OTC: PRTT) (“Company”) President, Ali Yildiz, provides its shareholders with the following informational update: "July 1, 2024 Dear Shareholders: The Company’s PCAOB audit for the fiscal year of 2023 is near completion. We have a few items remaining that are required to be completed by the local jurisdiction of the company in Turkey. We expect those items to be resolved in the coming days and should receive our aud Performance Overview Trailing total returns as of 2/21/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return PRTT S&P 500 YTD +81.98% +2.24% 1-Year -58.13% +20.70% 3-Year +329.17% +38.27%